Teva Pharmaceutical Industries Limited (TLV: TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
7,850.00
+52.00 (0.67%)
Jan 22, 2025, 10:19 AM IDT

TLV: TEVA Revenue

Teva Pharmaceutical Industries had revenue of $4.33B USD in the quarter ending September 30, 2024, with 12.52% growth. This brings the company's revenue in the last twelve months to $16.77B, up 9.81% year-over-year. In the year 2023, Teva Pharmaceutical Industries had annual revenue of $15.85B with 6.17% growth.

Revenue (ttm)
$16.77B
Revenue Growth
+9.81%
P/S Ratio
n/a
Revenue / Employee
$459.86K
Employees
36,472
Market Cap
87.95B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 201916.89B-1.38B-7.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Danel (Adir Yeoshua) 2.71B
Kamada 588.75M
Bait Bakfar 102.08M
Novolog (Pharm-Up 1966) 1.73B
Ilex Medical 982.96M
BrainsWay 143.60M
SofWave Medical 210.53M
Golden House 47.96M
Revenue Rankings